Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responses
Open Access
- 12 November 2009
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 27 (48), 6791-6798
- https://doi.org/10.1016/j.vaccine.2009.08.088
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responsesMucosal Immunology, 2009
- Characterization of the Rheological, Mucoadhesive, and Drug Release Properties of Highly Structured Gel Platforms for Intravaginal Drug DeliveryBiomacromolecules, 2009
- Behavioural strategies to reduce HIV transmission: how to make them work betterThe Lancet, 2008
- Toward an AIDS VaccineScience, 2008
- An HIV Vaccine — Evolving ConceptsNew England Journal of Medicine, 2007
- Structural definition of a conserved neutralization epitope on HIV-1 gp120Nature, 2007
- HIV/AIDS epidemiology, pathogenesis, prevention, and treatmentThe Lancet, 2006
- Thermosensitive and mucoadhesive delivery systems of mucosal vaccinesMethods, 2006
- Sexual transmission of HIV in AfricaNature, 2003
- Mucoadhesive, syringeable drug delivery systems for controlled application of metronidazole to the periodontal pocket: In vitro release kinetics, syringeability, mechanical and mucoadhesive propertiesJournal of Controlled Release, 1997